Home NDC 70121-2537 leuprolide acetate
Product NDC 70121-2537
11-digit product format 701212537
Labeler code 70121
Product ID 70121-2537_9f3b7704-ff08-4f2d-bd20-51c3f66f47e6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name leuprolide acetate
Dosage form KIT
Route SUBCUTANEOUS
Labeler Amneal Pharmaceuticals LLC
Application ANDA215336
Marketing category ANDA
Marketing start 2022-11-07
Marketing end 0000-00-00
Active strength 0
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215336-001 LEUPROLIDE ACETATE LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A215336-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 c2088c7a36db…2026-09-14 22:38:34 2026-08 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 84e616aacf4f…2026-08-18 06:07:40 2026-07 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A215336-001 LEUPROLIDE ACETATE 1MG/0.2ML INJECTABLE / INJECTION AP 2022-10-28 3a93d1ddd44b…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215336-001 LEUPROLIDE ACETATE 14MG/2.8ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS AP 2022-10-28 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70121-1695-2 leuprolide acetate 2.8 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 2.8 mL 5 mg in 1mL 9 70121-1695-2 leuprolide acetate 1 in 1 CARTON INJECTION, SOLUTION 5 mg in 1mL 9 70121-2537-6 leuprolide acetate 1 in 1 CARTON KIT 1 9 70121-2538-9 leuprolide acetate 1 mL in 1 PACKET SWAB 28 mL 0.7 mL in 1mL 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70121-2537 LEUPROLIDE ACETATE KIT [AMNEAL PHARMACEUTICALS LLC] 7 Legacy NDC, 4 package rows 20250427_4838c674-044e-46b2-81e7-c691b99d8fa5.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70121-1695-2 70121169502 2.8 mL in 1 VIAL, MULTI-DOSE 2.8 ml Historical 70121-2537-6 70121253706 1 KIT in 1 CARTON (70121-2537-6) * 1 VIAL, MULTI-DOSE in 1 CARTON (70121-1695-2) > 2.8 mL in 1 VIAL, MULTI-DOSE * 1 mL in 1 PACKET (70121-2538-9) 1 kit 2022-11-07 0000-00-00 No No Current 70121-2538-9 70121253809 1 mL in 1 PACKET 1 ml Historical